Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:33 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

The Effect of Oxytocin on the Acquisition and Consolidation of Trauma-Associated Memories

ClinicalTrials.gov · NCT03031405 · Registry updated: 2018-08-21

Condition / research focus: Intrusive Memories
Sponsor: Charite University, Berlin, Germany
Countries with listed sites: Germany
Registry dates and results: Start: 2017-01-15. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebos (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin
Berlin, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes

ClinicalTrials.gov · NCT03625518 · Registry updated: 2018-08-10

Condition / research focus: Fetal Growth Retardation; Induction of Labor Affected Fetus / Newborn
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2018-09. Completion: 2021-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

prostaglandins E2 (drug) — also listed as: dinoprostone slow release pessary
intracervical balloon catheter combined with pitocin (device)

Where the study takes place — 1 listed sites

Lis Maternity Hospital, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia

ClinicalTrials.gov · NCT01937013 · Registry updated: 2018-08-08

Condition / research focus: Frontotemporal Dementia
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Countries with listed sites: Canada
Registry dates and results: Start: 2013-09-12. Completion: 2017-12-21 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Syntocinon
Saline Nasal Mist (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

Parkwood Hospital
London, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of Intranasal Oxytocin and Stress on Belief Updating

ClinicalTrials.gov · NCT03597893 · Registry updated: 2018-07-24

Condition / research focus: Healthy
Sponsor: Beijing Normal University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-12-27. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug) — also listed as: Saline

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering

ClinicalTrials.gov · NCT02441673 · Registry updated: 2018-07-17

Condition / research focus: Post Anaesthetic Shivering
Sponsor: Lagos State Health Service Commission
Countries with listed sites: No country reported
Registry dates and results: Start: 2018-10-12. Completion: 2019-06 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nefopam (drug) — also listed as: Acupan
Tramadol (drug)
Metoclopramide (drug)
Ranitidine (drug)
Pethidine (drug)
Ephedrine (drug)
oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Interaction Between Oxytocin and Serotonin

ClinicalTrials.gov · NCT03577457 · Registry updated: 2018-07-12

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2018-02-01. Completion: 2019-07-20 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin nasal spray (drug)
ATD treatment (drug)
intranasal placebo treatment (placebo-control for oxytocin) (drug)
oral placebo treatment (placebo-control for ATD) (drug)

Where the study takes place — 1 listed sites

Beijing Normal University
Beijing, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Oxytocin and Arginine Vasopressin in Pain Relief

ClinicalTrials.gov · NCT01328561 · Registry updated: 2018-07-05

Condition / research focus: Placebo Analgesia
Sponsor: National Institute of Mental Health (NIMH)
Countries with listed sites: United States
Registry dates and results: Start: 2011-03-17. Completion: 2015-03-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals

ClinicalTrials.gov · NCT01963091 · Registry updated: 2018-06-04

Condition / research focus: Cocaine Dependence
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2012-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: pitocin
saline (drug)

Where the study takes place — 1 listed sites

Clinical Neurosciences Division-MUSC
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Prolonged Exposure and Oxytocin

ClinicalTrials.gov · NCT03238924 · Registry updated: 2018-05-25

Condition / research focus: PTSD
Sponsor: Medical University of South Carolina
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-01-01. Completion: 2016-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebos (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

ClinicalTrials.gov · NCT03308643 · Registry updated: 2018-05-21

Condition / research focus: Myomectomy
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2017-10-01. Completion: 2018-05-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
saline (other)

Where the study takes place — 1 listed sites

Kanuni Sultan Suleyman Egitim ve Arastırma Hastanesi
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain

ClinicalTrials.gov · NCT02642263 · Registry updated: 2018-05-04

Condition / research focus: Cesarean Delivery
Sponsor: Insel Gruppe AG, University Hospital Bern
Countries with listed sites: Switzerland
Registry dates and results: Start: 2019-02-01. Completion: 2022-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal, Ferring, Baar, Switzerland

Where the study takes place — 1 listed sites

Dep. of Anesthesiology and Pain Medicine, Bern University Hospital
Bern, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Modulation of Reinforcement Learning

ClinicalTrials.gov · NCT01712464 · Registry updated: 2018-05-01

Condition / research focus: Impact of Oxytocin on Social Learning
Sponsor: RWTH Aachen University
Countries with listed sites: Germany
Registry dates and results: Start: 2013-10-18. Completion: 2016-08-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin vs. Placebo (drug)

Where the study takes place — 1 listed sites

Universtiy Hospital Aachen
Aachen, Northrhine-Westfalia, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

ClinicalTrials.gov · NCT02954068 · Registry updated: 2018-04-30

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Argentina
Registry dates and results: Start: 2016-12-01. Completion: 2017-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IV Oxytocin + IM placebo (drug)
IM Oxytocin + IV placebo (drug)

Where the study takes place — 1 listed sites

Hospital J.R. Vidal
Corrientes, Argentina
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3UnknownINTERVENTIONAL

The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.

ClinicalTrials.gov · NCT03509168 · Registry updated: 2018-04-30

Condition / research focus: Uterine Fibroid
Sponsor: Makerere University
Countries with listed sites: Uganda
Registry dates and results: Start: 2018-01-10. Completion: 2018-06-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol Pfizer Brand (drug) — also listed as: cytotec
Non-insertion of Misoprostol Pfizer Brand (other)

Where the study takes place — 1 listed sites

Makerere University
Kampala, Central Region, Uganda
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Oxytocin Administration During Cesarean Section

ClinicalTrials.gov · NCT03344302 · Registry updated: 2018-04-23

Condition / research focus: Postpartum Hemorrhage
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-10. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Assiut Faculty of Medicine
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1WithdrawnINTERVENTIONAL

Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin

ClinicalTrials.gov · NCT02911480 · Registry updated: 2018-04-06

Condition / research focus: Healthy Women of Child Bearing Potential
Sponsor: Oxytone Bioscience BV
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04. Completion: 2017-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Misoprostol Labour Induction Study

ClinicalTrials.gov · NCT03489928 · Registry updated: 2018-04-06

Condition / research focus: Induction of Labour; Labour, Induced
Sponsor: David Young
Countries with listed sites: No country reported
Registry dates and results: Start: 1999-04-01. Completion: 2000-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oral Misoprostol (drug) — also listed as: Oral Cytotec
Vaginal Misoprostol (drug) — also listed as: Vaginal Cytotec
Dinoprostone (drug) — also listed as: Prostin

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Trial in Prader-Willi Syndrome

ClinicalTrials.gov · NCT02013258 · Registry updated: 2018-04-05

Condition / research focus: Prader Willi Syndrome
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2015-03. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Pitocin, Syntocinon
Placebo (other)

Where the study takes place — 3 listed sites

University of California, Irvine
Orange, California, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
University of Kansas Medical Center
Kansas City, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor

ClinicalTrials.gov · NCT02566005 · Registry updated: 2018-03-27

Condition / research focus: Pregnancy
Sponsor: St. Luke's-Roosevelt Hospital Center
Countries with listed sites: United States
Registry dates and results: Start: 2015-09. Completion: 2016-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (device) — also listed as: cytotec
Foley bulb (device) — also listed as: foley bulb (ballon)

Where the study takes place — 1 listed sites

Mount Sinai Roosevelt
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes

ClinicalTrials.gov · NCT03310333 · Registry updated: 2018-02-19

Condition / research focus: PROM (Premature Rupture Of Foetal Membrane)
Sponsor: University Hospital, Clermont-Ferrand
Countries with listed sites: France
Registry dates and results: Start: 2018-02-14. Completion: 2020-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Propess® (dinoprostone) (drug)
cook cervical pipening balloon (device)

Where the study takes place — 1 listed sites

CHU Clermont-Ferrand
Clermont-Ferrand, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 23:33 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableCompletedINTERVENTIONAL

The Effect of Oxytocin on the Acquisition and Consolidation of Trauma-Associated Memories

ClinicalTrials.gov · NCT03031405 · Registry updated: 2018-08-21

Condition / research focus: Intrusive Memories
Sponsor: Charite University, Berlin, Germany
Countries with listed sites: Germany
Registry dates and results: Start: 2017-01-15. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebos (drug)

Where the study takes place — 1 listed sites

Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin Franklin
Berlin, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1UnknownINTERVENTIONAL

Mode of Induction in Fetal Growth Restriction and Its Affects on Fetal and Maternal Outcomes

ClinicalTrials.gov · NCT03625518 · Registry updated: 2018-08-10

Condition / research focus: Fetal Growth Retardation; Induction of Labor Affected Fetus / Newborn
Sponsor: Tel-Aviv Sourasky Medical Center
Countries with listed sites: Israel
Registry dates and results: Start: 2018-09. Completion: 2021-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

prostaglandins E2 (drug) — also listed as: dinoprostone slow release pessary
intracervical balloon catheter combined with pitocin (device)

Where the study takes place — 1 listed sites

Lis Maternity Hospital, Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia

ClinicalTrials.gov · NCT01937013 · Registry updated: 2018-08-08

Condition / research focus: Frontotemporal Dementia
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Countries with listed sites: Canada
Registry dates and results: Start: 2013-09-12. Completion: 2017-12-21 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Syntocinon
Saline Nasal Mist (drug) — also listed as: Placebo

Where the study takes place — 1 listed sites

Parkwood Hospital
London, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effects of Intranasal Oxytocin and Stress on Belief Updating

ClinicalTrials.gov · NCT03597893 · Registry updated: 2018-07-24

Condition / research focus: Healthy
Sponsor: Beijing Normal University
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-12-27. Completion: 2018-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
Placebo (drug) — also listed as: Saline

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

Nefopam vs Tramadol in the Prevention of Post Anaesthetic Shivering

ClinicalTrials.gov · NCT02441673 · Registry updated: 2018-07-17

Condition / research focus: Post Anaesthetic Shivering
Sponsor: Lagos State Health Service Commission
Countries with listed sites: No country reported
Registry dates and results: Start: 2018-10-12. Completion: 2019-06 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nefopam (drug) — also listed as: Acupan
Tramadol (drug)
Metoclopramide (drug)
Ranitidine (drug)
Pethidine (drug)
Ephedrine (drug)
oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

The Interaction Between Oxytocin and Serotonin

ClinicalTrials.gov · NCT03577457 · Registry updated: 2018-07-12

Condition / research focus: Healthy
Sponsor: University of Electronic Science and Technology of China
Countries with listed sites: China
Registry dates and results: Start: 2018-02-01. Completion: 2019-07-20 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin nasal spray (drug)
ATD treatment (drug)
intranasal placebo treatment (placebo-control for oxytocin) (drug)
oral placebo treatment (placebo-control for ATD) (drug)

Where the study takes place — 1 listed sites

Beijing Normal University
Beijing, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Oxytocin and Arginine Vasopressin in Pain Relief

ClinicalTrials.gov · NCT01328561 · Registry updated: 2018-07-05

Condition / research focus: Placebo Analgesia
Sponsor: National Institute of Mental Health (NIMH)
Countries with listed sites: United States
Registry dates and results: Start: 2011-03-17. Completion: 2015-03-04 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals

ClinicalTrials.gov · NCT01963091 · Registry updated: 2018-06-04

Condition / research focus: Cocaine Dependence
Sponsor: Medical University of South Carolina
Countries with listed sites: United States
Registry dates and results: Start: 2011-07. Completion: 2012-10 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

oxytocin (drug) — also listed as: pitocin
saline (drug)

Where the study takes place — 1 listed sites

Clinical Neurosciences Division-MUSC
Charleston, South Carolina, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Prolonged Exposure and Oxytocin

ClinicalTrials.gov · NCT03238924 · Registry updated: 2018-05-25

Condition / research focus: PTSD
Sponsor: Medical University of South Carolina
Countries with listed sites: No country reported
Registry dates and results: Start: 2015-01-01. Completion: 2016-12-31 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug) — also listed as: Pitocin
Placebos (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Effect of Oxytocin Infusion on Blood Loss During Abdominal Myomectomy

ClinicalTrials.gov · NCT03308643 · Registry updated: 2018-05-21

Condition / research focus: Myomectomy
Sponsor: Kanuni Sultan Suleyman Training and Research Hospital
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2017-10-01. Completion: 2018-05-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)
saline (other)

Where the study takes place — 1 listed sites

Kanuni Sultan Suleyman Egitim ve Arastırma Hastanesi
Istanbul, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain

ClinicalTrials.gov · NCT02642263 · Registry updated: 2018-05-04

Condition / research focus: Cesarean Delivery
Sponsor: Insel Gruppe AG, University Hospital Bern
Countries with listed sites: Switzerland
Registry dates and results: Start: 2019-02-01. Completion: 2022-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Carbetocin (drug) — also listed as: Pabal, Ferring, Baar, Switzerland

Where the study takes place — 1 listed sites

Dep. of Anesthesiology and Pain Medicine, Bern University Hospital
Bern, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Modulation of Reinforcement Learning

ClinicalTrials.gov · NCT01712464 · Registry updated: 2018-05-01

Condition / research focus: Impact of Oxytocin on Social Learning
Sponsor: RWTH Aachen University
Countries with listed sites: Germany
Registry dates and results: Start: 2013-10-18. Completion: 2016-08-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin vs. Placebo (drug)

Where the study takes place — 1 listed sites

Universtiy Hospital Aachen
Aachen, Northrhine-Westfalia, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

ClinicalTrials.gov · NCT02954068 · Registry updated: 2018-04-30

Condition / research focus: Postpartum Hemorrhage
Sponsor: Gynuity Health Projects
Countries with listed sites: Argentina
Registry dates and results: Start: 2016-12-01. Completion: 2017-10-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

IV Oxytocin + IM placebo (drug)
IM Oxytocin + IV placebo (drug)

Where the study takes place — 1 listed sites

Hospital J.R. Vidal
Corrientes, Argentina
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3UnknownINTERVENTIONAL

The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy.

ClinicalTrials.gov · NCT03509168 · Registry updated: 2018-04-30

Condition / research focus: Uterine Fibroid
Sponsor: Makerere University
Countries with listed sites: Uganda
Registry dates and results: Start: 2018-01-10. Completion: 2018-06-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol Pfizer Brand (drug) — also listed as: cytotec
Non-insertion of Misoprostol Pfizer Brand (other)

Where the study takes place — 1 listed sites

Makerere University
Kampala, Central Region, Uganda
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Oxytocin Administration During Cesarean Section

ClinicalTrials.gov · NCT03344302 · Registry updated: 2018-04-23

Condition / research focus: Postpartum Hemorrhage
Sponsor: Assiut University
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-10. Completion: 2017-09 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 1 listed sites

Assiut Faculty of Medicine
Asyut, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1WithdrawnINTERVENTIONAL

Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin

ClinicalTrials.gov · NCT02911480 · Registry updated: 2018-04-06

Condition / research focus: Healthy Women of Child Bearing Potential
Sponsor: Oxytone Bioscience BV
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04. Completion: 2017-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Misoprostol Labour Induction Study

ClinicalTrials.gov · NCT03489928 · Registry updated: 2018-04-06

Condition / research focus: Induction of Labour; Labour, Induced
Sponsor: David Young
Countries with listed sites: No country reported
Registry dates and results: Start: 1999-04-01. Completion: 2000-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oral Misoprostol (drug) — also listed as: Oral Cytotec
Vaginal Misoprostol (drug) — also listed as: Vaginal Cytotec
Dinoprostone (drug) — also listed as: Prostin

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin Trial in Prader-Willi Syndrome

ClinicalTrials.gov · NCT02013258 · Registry updated: 2018-04-05

Condition / research focus: Prader Willi Syndrome
Sponsor: University of Florida
Countries with listed sites: United States
Registry dates and results: Start: 2015-03. Completion: 2015-08 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal oxytocin (drug) — also listed as: Pitocin, Syntocinon
Placebo (other)

Where the study takes place — 3 listed sites

University of California, Irvine
Orange, California, United States
Site recruitment: Not reported
University of Florida
Gainesville, Florida, United States
Site recruitment: Not reported
University of Kansas Medical Center
Kansas City, Kansas, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

A Randomized Comparison of Transcervical Foley Bulb With Vaginal Misoprostol to Vaginal Misoprostol Alone for Induction of Labor

ClinicalTrials.gov · NCT02566005 · Registry updated: 2018-03-27

Condition / research focus: Pregnancy
Sponsor: St. Luke's-Roosevelt Hospital Center
Countries with listed sites: United States
Registry dates and results: Start: 2015-09. Completion: 2016-07 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

misoprostol (device) — also listed as: cytotec
Foley bulb (device) — also listed as: foley bulb (ballon)

Where the study takes place — 1 listed sites

Mount Sinai Roosevelt
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Cook Balloon Versus Propess After 12 Hours of Rupture of Membranes

ClinicalTrials.gov · NCT03310333 · Registry updated: 2018-02-19

Condition / research focus: PROM (Premature Rupture Of Foetal Membrane)
Sponsor: University Hospital, Clermont-Ferrand
Countries with listed sites: France
Registry dates and results: Start: 2018-02-14. Completion: 2020-07-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Propess® (dinoprostone) (drug)
cook cervical pipening balloon (device)

Where the study takes place — 1 listed sites

CHU Clermont-Ferrand
Clermont-Ferrand, France
Site recruitment: Recruiting

Original record, eligibility, contacts and results →